CY2016042I1 - NEW HETEROCYCLIC COMPOUNDS ACTIVE AS BETA-LACTAMAS INHIBITORS - Google Patents

NEW HETEROCYCLIC COMPOUNDS ACTIVE AS BETA-LACTAMAS INHIBITORS

Info

Publication number
CY2016042I1
CY2016042I1 CY2016042C CY2016042C CY2016042I1 CY 2016042 I1 CY2016042 I1 CY 2016042I1 CY 2016042 C CY2016042 C CY 2016042C CY 2016042 C CY2016042 C CY 2016042C CY 2016042 I1 CY2016042 I1 CY 2016042I1
Authority
CY
Cyprus
Prior art keywords
lactamas
inhibitors
beta
heterocyclic compounds
compounds active
Prior art date
Application number
CY2016042C
Other languages
Greek (el)
Other versions
CY2016042I2 (en
Original Assignee
Astra Zeneca Holding France
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27619669&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY2016042(I1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astra Zeneca Holding France filed Critical Astra Zeneca Holding France
Publication of CY2016042I1 publication Critical patent/CY2016042I1/en
Publication of CY2016042I2 publication Critical patent/CY2016042I2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4995—Pyrazines or piperazines forming part of bridged ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
CY2016042C 2002-01-28 2016-12-06 NEW HETEROCYCLIC COMPOUNDS ACTIVE AS BETA-LACTAMAS INHIBITORS CY2016042I2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0200951A FR2835186B1 (en) 2002-01-28 2002-01-28 NOVEL HETEROCYCLIC COMPOUNDS ACTIVE AS BETA-LACTAMASES INHIBITORS
PCT/FR2003/000243 WO2003063864A2 (en) 2002-01-28 2003-01-27 Heterocyclic compounds which are active as inhibitors of beta lactamases

Publications (2)

Publication Number Publication Date
CY2016042I1 true CY2016042I1 (en) 2017-03-15
CY2016042I2 CY2016042I2 (en) 2017-03-15

Family

ID=27619669

Family Applications (3)

Application Number Title Priority Date Filing Date
CY20101101192T CY1111061T1 (en) 2002-01-28 2010-12-23 NEW HYDROCYCLIC UNIONS ACTIVE AS BETA-LACTAMA INHIBITIONS
CY20131100090T CY1114417T1 (en) 2002-01-28 2013-01-31 Heterocyclic compounds, active as inhibitors of beta-lactams
CY2016042C CY2016042I2 (en) 2002-01-28 2016-12-06 NEW HETEROCYCLIC COMPOUNDS ACTIVE AS BETA-LACTAMAS INHIBITORS

Family Applications Before (2)

Application Number Title Priority Date Filing Date
CY20101101192T CY1111061T1 (en) 2002-01-28 2010-12-23 NEW HYDROCYCLIC UNIONS ACTIVE AS BETA-LACTAMA INHIBITIONS
CY20131100090T CY1114417T1 (en) 2002-01-28 2013-01-31 Heterocyclic compounds, active as inhibitors of beta-lactams

Country Status (45)

Country Link
US (4) US7612087B2 (en)
EP (2) EP1480644B1 (en)
JP (1) JP4472346B2 (en)
KR (1) KR100979079B1 (en)
CN (3) CN101406471A (en)
AR (2) AR038234A1 (en)
AT (1) ATE484281T1 (en)
AU (1) AU2003214335B2 (en)
BE (1) BE2016C069I2 (en)
BR (1) BRPI0307267B8 (en)
CA (1) CA2474043C (en)
CL (1) CL2011000009A1 (en)
CO (1) CO5601014A2 (en)
CR (2) CR7387A (en)
CY (3) CY1111061T1 (en)
DE (1) DE60334527D1 (en)
DK (2) DK1480644T3 (en)
EA (1) EA007220B1 (en)
EC (1) ECSP045193A (en)
ES (2) ES2401855T3 (en)
FR (1) FR2835186B1 (en)
HK (2) HK1077205A1 (en)
HR (1) HRP20040686B1 (en)
HU (1) HUS1600055I1 (en)
IL (1) IL163167A (en)
JO (1) JO2646B1 (en)
LT (1) LTC1480644I2 (en)
MA (1) MA26351A1 (en)
MX (1) MXPA04006621A (en)
MY (1) MY140638A (en)
NL (1) NL300847I2 (en)
NO (2) NO335195B1 (en)
NZ (1) NZ533936A (en)
OA (1) OA12761A (en)
PE (1) PE20030969A1 (en)
PL (1) PL220725B1 (en)
PT (2) PT2279737E (en)
RS (1) RS52137B (en)
SI (2) SI1480644T1 (en)
TN (1) TNSN04137A1 (en)
TW (1) TWI293071B (en)
UA (1) UA80271C2 (en)
UY (1) UY27626A1 (en)
WO (1) WO2003063864A2 (en)
ZA (1) ZA200405607B (en)

Families Citing this family (83)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2812635B1 (en) * 2000-08-01 2002-10-11 Aventis Pharma Sa NOVEL HETEROCYCLIC COMPOUNDS, PREPARATION AND USE AS MEDICAMENTS IN PARTICULAR AS ANTI-BACTERIALS
FR2835186B1 (en) * 2002-01-28 2006-10-20 Aventis Pharma Sa NOVEL HETEROCYCLIC COMPOUNDS ACTIVE AS BETA-LACTAMASES INHIBITORS
FR2844273B1 (en) 2002-09-05 2008-04-04 Aventis Pharma Sa NOVEL HETEROCYCLIC COMPOUNDS, METHOD AND INTERMEDIARY PREPARATION AND USE AS MEDICAMENT, IN PARTICULAR AS INHIBITORS OF BETA-LACTAMASES AND ANTI-BACTERIALS.
FR2848210B1 (en) * 2002-12-06 2007-10-19 Aventis Pharma Sa NOVEL HETEROCYCLIC COMPOUNDS, PREPARATION THEREOF AND THEIR USE AS MEDICAMENTS, IN PARTICULAR AS ANTI-BACTERIALS AND INHIBITORS OF BETA-LACTAMASES
US7439253B2 (en) * 2002-12-06 2008-10-21 Novexel Heterocyclic compounds, their preparation and their use as medicaments, in particular as antibacterials and beta-lactamase inhibitors
US8900637B2 (en) * 2005-12-02 2014-12-02 Lupin Limited Stable taste masked formulations of cephalosporins
EP1965798B1 (en) 2005-12-07 2011-10-19 Basilea Pharmaceutica AG Useful monobactam antibiotics
US20090298878A1 (en) * 2006-07-14 2009-12-03 Akira Matsumura Oxime compounds and the use thereof
WO2008051763A1 (en) * 2006-10-23 2008-05-02 Irm Llc Cathepsin proteases inhibitors
WO2008150470A1 (en) * 2007-05-31 2008-12-11 Shionogi & Co., Ltd. Oxyimino compounds and the use thereof
FR2921060B1 (en) 2007-09-14 2012-06-15 Novexel NOVEL PROCESS FOR PREPARING DISUBSIDED PIPERIDINE AND NOVEL INTERMEDIATES
SI2231667T1 (en) * 2008-01-18 2013-12-31 Merck Sharp & Dohme Corp. Beta-lactamase inhibitors
WO2009114921A1 (en) * 2008-03-17 2009-09-24 Dmitrienko Gary I INHIBITORS OF CLASS B AND CLASS D β-LACTAMASES
FR2930553B1 (en) * 2008-04-29 2010-05-21 Novexel AZABICYCLIC COMPOUNDS, THEIR PREPARATION AND THEIR USE AS MEDICAMENTS, IN PARTICULAR BETA-LACTAMASES INHIBITORS
JP5501983B2 (en) * 2008-06-11 2014-05-28 塩野義製薬株式会社 Oxycarbamoyl compounds and uses thereof
FR2936798B1 (en) * 2008-10-03 2012-09-28 Novexel NOVEL HETEROCYCLIC NITROGEN COMPOUNDS, THEIR PREPARATION AND THEIR USE AS ANTIBACTERIAL MEDICINES.
FR2936951B1 (en) * 2008-10-10 2010-12-03 Novexel NOVEL COMBINATIONS OF ANTIBACTERIAL NITROGENIC HETEROCYCLIC COMPOUNDS WITH OTHER ANTIBACTERIAL COMPOUNDS AND THEIR USE AS MEDICAMENTS
FR2937034B1 (en) * 2008-10-10 2012-11-23 Novexel NOVEL HETEROCYCLIC NITROGEN COMPOUNDS, THEIR PREPARATION AND THEIR USE AS ANTIBACTERIAL MEDICINES
AU2014244235B2 (en) * 2009-10-09 2016-04-21 Pfizer Ireland Pharmaceuticals Polymorphic and pseudopolymorphic forms of a pharmaceutical compound
FR2951171A1 (en) 2009-10-09 2011-04-15 Novexel NOVEL SODIUM SALT OF A CRYSTALLIZED ENANTIOMER AZABICYCLIC COMPOUND AND NOVEL POLYMORPHIC AND PSEUDOPOLYMORPHIC FORMS AND THEIR PREPARATION
KR102087313B1 (en) 2010-08-10 2020-03-11 렘펙스 파머수티클스 인코퍼레이티드 Method for preparing cyclic boronic acid ester derivatives
ES2622004T3 (en) * 2010-12-22 2017-07-05 Meiji Seika Pharma Co., Ltd. Optically active diazabicyclooctane derivative and method for preparing it
US8772490B2 (en) * 2010-12-22 2014-07-08 Meiji Seika Pharma Co., Ltd. Optically active diazabicyclooctane derivatives and process for preparing the same
WO2012172368A1 (en) * 2011-06-17 2012-12-20 Astrazeneca Ab Process for preparing heterocyclic compounds including trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide and salts thereof
PL2748165T3 (en) * 2011-08-27 2017-05-31 Wockhardt Limited 1,6-diazabicyclo[3,2,1]octan-7-one derivatives and their use in the treatment of bacterial infections.
US9102683B2 (en) 2011-08-29 2015-08-11 University Of Utah Research Foundation Heterocyclic compounds
US20130053565A1 (en) * 2011-08-29 2013-02-28 University Of Utah Research Foundation Substituted 3-piperidone compounds
US9012491B2 (en) 2011-08-31 2015-04-21 Rempex Pharmaceuticals, Inc. Heterocyclic boronic acid ester derivatives and therapeutic uses thereof
MX349827B (en) * 2011-09-13 2017-08-14 Wockhardt Ltd Nitrogen containing compounds and their use.
US8969567B2 (en) * 2011-09-13 2015-03-03 Wockhardt Ltd. Nitrogen containing compounds and their use
US9505761B2 (en) 2011-12-02 2016-11-29 Fedora Pharmaceuticals Inc. Bicyclic compounds and their use as antibacterial agents and beta-lactamase inhibitors
US8796257B2 (en) 2011-12-02 2014-08-05 Naeja Pharmaceutical Inc. Bicyclic compounds and their use as antibacterial agents and β-lactamase inhibitors
US8969570B2 (en) 2012-03-30 2015-03-03 Cubist Pharmaceuticals, Inc. Beta-lactamase inhibitors
SG11201406120SA (en) 2012-03-30 2014-10-30 Cubist Pharm Inc ISOXAZOLE β-LACTAMASE INHIBITORS
US8916709B2 (en) 2012-03-30 2014-12-23 Cubist Pharmaceuticals, Inc. 1,2,4-oxadiazole and 1,2,4-thiadiazole β-lactamase inhibitors
TW201343645A (en) 2012-03-30 2013-11-01 Cubist Pharm Inc 1,3,4-oxadiazole and 1,3,4-thiadiazole β-lactamase inhibitors
AR090539A1 (en) * 2012-04-02 2014-11-19 Astrazeneca Ab INHIBITING COMPOUNDS OF B LACTAMASA
US9156858B2 (en) 2012-05-23 2015-10-13 Rempex Pharmaceuticals, Inc. Boronic acid derivatives and therapeutic uses thereof
RU2693898C2 (en) 2012-05-30 2019-07-05 Мейдзи Сейка Фарма Ко., Лтд. Novel beta-lactamase inhibitor and method for production thereof
US10561675B2 (en) 2012-06-06 2020-02-18 Rempex Pharmaceuticals, Inc. Cyclic boronic acid ester derivatives and therapeutic uses thereof
EP2961751B1 (en) * 2012-08-25 2018-03-21 Wockhardt Limited 1,6- diazabicyclo [3,2,1]octan- 7- one derivatives and their use in the treatment of bacterial infections
UA111925C2 (en) * 2012-12-11 2016-06-24 Федора Фармасьютікалз Інк. BICYCLIC COMPOUNDS AND THEIR USE AS ANTIBACTERIAL AGENTS AND β-LACTAMASE INHIBITORS
EA201591003A1 (en) 2013-01-04 2015-12-30 Ремпекс Фармасьютикалз, Инк. DERIVATIVES OF BORONIC ACID AND THEIR THERAPEUTIC APPLICATION
US9101638B2 (en) 2013-01-04 2015-08-11 Rempex Pharmaceuticals, Inc. Boronic acid derivatives and therapeutic uses thereof
MX2015008627A (en) 2013-01-04 2015-09-23 Rempex Pharmaceuticals Inc Boronic acid derivatives and therapeutic uses thereof.
US9241947B2 (en) 2013-01-04 2016-01-26 Rempex Pharmaceuticals, Inc. Boronic acid derivatives and therapeutic uses thereof
US9120795B2 (en) 2013-03-14 2015-09-01 Cubist Pharmaceuticals, Inc. Crystalline form of a β-lactamase inhibitor
NZ718009A (en) 2013-09-24 2018-03-23 Meiji Seika Pharma Co Ltd Process for producing diazabicyclooctane derivative and intermediate thereof
WO2015051101A1 (en) 2013-10-02 2015-04-09 Cubist Pharmaceuticals, Inc. B-lactamase inhibitor picoline salt
HUE051925T2 (en) 2013-10-08 2021-04-28 Meiji Seika Pharma Co Ltd Crystals of diazabicyclooctane derivative and production method for crystals of diazabicyclooctane derivative
JP2017506240A (en) * 2014-02-20 2017-03-02 ウォックハート リミテッド Pharmaceutical composition comprising an antibacterial agent
CN103896936A (en) * 2014-03-20 2014-07-02 西安交通大学 (5S, 6R) cloxacillin penicilloate as well as preparation method and application thereof
US10385074B2 (en) 2014-05-05 2019-08-20 Rempex Pharmaceuticals, Inc. Synthesis of boronate salts and uses thereof
EP3139930A4 (en) 2014-05-05 2018-01-17 Rempex Pharmaceuticals, Inc. Salts and polymorphs of cyclic boronic acid ester derivatives and therapeutic uses thereof
JP6672176B2 (en) 2014-05-19 2020-03-25 レンペックス・ファーマシューティカルズ・インコーポレイテッド Boronic acid derivatives and their therapeutic use
CN104059083B (en) * 2014-05-27 2017-01-04 浙江工业大学 A kind of method of asymmetric synthesis of chirality bicyclo-caprolactam compounds
AU2015284307A1 (en) 2014-07-01 2017-02-02 Rempex Pharmaceuticals, Inc. Boronic acid derivatives and therapeutic uses thereof
JP6764862B2 (en) * 2014-11-17 2020-10-07 エンタシス・セラピューティックス・リミテッド Combination therapy for the treatment of resistant bacterial infections
US10662205B2 (en) 2014-11-18 2020-05-26 Qpex Biopharma, Inc. Cyclic boronic acid ester derivatives and therapeutic uses thereof
KR102555657B1 (en) 2014-12-05 2023-07-18 메이지 세이카 파루마 가부시키가이샤 Method for producing crystals of diazabicyclooctane derivative and stable lyophilized preparation
US20180051041A1 (en) 2015-03-17 2018-02-22 Rempex Pharmaceuticals, Inc. Boronic acid derivatives and therapeutic uses thereof
TWI754613B (en) * 2015-05-07 2022-02-11 法商木塔比利斯公司 Heterocyclic compounds and their use in preventing or treating bacterial infections
WO2017045510A1 (en) * 2015-09-16 2017-03-23 山东轩竹医药科技有限公司 Β-lactamase inhibitor and application thereof
US9951072B2 (en) 2015-10-02 2018-04-24 Legochem Biosciences, Inc. Compositions and methods for inhibiting beta-lactamase
WO2017156458A1 (en) 2016-03-11 2017-09-14 University Of South Florida Beta-lactamase inhibitors, formulations, and uses thereof
EP3156400B1 (en) 2016-05-27 2019-05-15 Valoralia I Más D, SL Dihydrooxadiazine compounds for treating infections and cancer
UA124464C2 (en) 2016-06-30 2021-09-22 Кьюпекс Біофарма, Інк. Boronic acid derivatives and therapeutic uses thereof
CN106279163A (en) * 2016-08-12 2017-01-04 上海龙翔生物医药开发有限公司 A kind of method synthesizing A Wei Batan and intermediate optical isomer thereof
CN107789355B (en) * 2016-09-07 2022-04-12 湘北威尔曼制药股份有限公司 Compound pharmaceutical composition containing piperacillin and application thereof
IL289686B2 (en) 2016-09-16 2023-03-01 Entasis Therapeutics Ltd Beta-lactamase inhibitor compounds
JOP20190061A1 (en) 2016-09-28 2019-03-26 Novartis Ag Beta-lactamase inhibitors
CN106699756B (en) * 2016-12-30 2019-10-29 淄博鑫泉医药技术服务有限公司 The synthetic method of beta lactamase restrainer AVM hereinafter Batan
CA3051972A1 (en) 2017-02-06 2018-08-09 Mutabilis Novel heterocyclic compounds and their use in preventing or treating bacterial infections
PL3630111T3 (en) 2017-05-08 2022-05-23 Entasis Therapeutics, Inc. Compounds and methods for treating bacterial infections
WO2018234962A1 (en) 2017-06-20 2018-12-27 Wockhardt Limited Process for o-sulfonation of 1,6-diazabicyclo[3.2.1]octane compounds
CA3078627A1 (en) 2017-10-11 2019-04-18 Qpex Biopharma, Inc. Boronic acid derivatives and synthesis thereof
CN109678856B (en) * 2017-10-18 2020-09-25 新发药业有限公司 Preparation method of avibactam intermediate
WO2019093450A1 (en) * 2017-11-10 2019-05-16 塩野義製薬株式会社 Diazabicyclooctane derivative
US11905286B2 (en) 2018-08-09 2024-02-20 Antabio Sas Diazabicyclooctanones as inhibitors of serine beta-lactamases
CN109942579B (en) * 2019-04-18 2021-06-22 成都千禧莱医药科技有限公司 Beta-lactamase inhibitor urea-containing bicyclic compound and preparation method and application thereof
WO2022047603A1 (en) * 2020-09-01 2022-03-10 Ningxia Academy Of Agriculture And Forestry Sciences Beta-lactamase inhibitors and their preparation
WO2022047790A1 (en) * 2020-09-07 2022-03-10 Ningxia Academy Of Agriculture And Forestry Sciences Amidine substituted bicyclic compounds, their preparation, their use as antibacterial agents and beta-lactamase inhibitors
WO2023060369A1 (en) * 2021-10-11 2023-04-20 Ningxia Academy Of Agriculture And Forestry Sciences Novel carbimidate substituted bicyclic compounds and their use as beta-lactamase inhibitors

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0260057A3 (en) 1986-09-02 1989-02-01 The University Of Melbourne 2-oxo-4-carboxy-pyrimidines
ATE117688T1 (en) 1989-06-09 1995-02-15 Upjohn Co HETEROCYCLIC AMINE WITH CNS ACTIVITY.
FR2676230B1 (en) 1991-05-07 1993-08-27 Centre Nat Rech Scient NOVEL PYRROLO [1,4] -BENZODIAZEPINES DERIVATIVES, PROCESS FOR THEIR PREPARATION AND MEDICAMENTS CONTAINING THEM.
JPH05339263A (en) 1992-06-08 1993-12-21 Wakunaga Pharmaceut Co Ltd Dihydropyridine derivative
PT1227103E (en) 1993-09-29 2006-12-29 Univ Maryland Ring-expanded nucleosides and nucleotides
WO1995018129A1 (en) * 1993-12-29 1995-07-06 Pfizer Inc. Diazabicyclic neurokinin antagonists
EP0702004A2 (en) * 1994-09-15 1996-03-20 Ciba-Geigy Ag 2,9-diamino- and 2-amino-8-carbamoyl-4-hydroxy-alkanoic acid amid derivatives
GB9505538D0 (en) 1995-03-18 1995-05-03 Ciba Geigy Ag New compounds
SE9504618D0 (en) 1995-12-22 1995-12-22 Astra Ab New Compounds
KR19990076988A (en) * 1996-01-03 1999-10-25 피터 기딩스 Carbamoyloxy derivatives of methiline and their use as antimicrobial agents
DE19627431A1 (en) 1996-07-08 1998-01-15 Bayer Ag Heterocyclically fused pyridines
UA51716C2 (en) 1996-07-08 2002-12-16 Авентіс Фармасьютікалз Продактс Інк. combinations possessing hypotensive, cardioprotective, anti-ishemic, and antilipolytic agents, a pharmaceutical composition and METHOD OF TREATMENT
HUP0001741A3 (en) * 1996-08-02 2000-11-28 Smithkline Beecham Plc Azabicyclic carbamoyloxy mutilin derivatives for antibacterial use, process for preparing them, pharmaceuticals contg. them and their use
TW527355B (en) 1997-07-02 2003-04-11 Bristol Myers Squibb Co Inhibitors of farnesyl protein transferase
US5994340A (en) * 1997-08-29 1999-11-30 Synphar Laboratories, Inc. Azetidinone derivatives as β-lactamase inhibitors
US6197339B1 (en) 1997-09-30 2001-03-06 Pharmacia & Upjohn Company Sustained release tablet formulation to treat Parkinson's disease
UY25225A1 (en) * 1997-10-29 2000-12-29 Smithkline Beecham Plc PLEUROMUTILINE DERIVATIVES USEFUL AS ANTIMICROBIAL AGENTS
US6329389B1 (en) 1998-04-08 2001-12-11 Takeda Chemical Industries, Ltd. Amine compounds, their production and use
WO2000000479A1 (en) 1998-06-30 2000-01-06 Du Pont Pharmaceuticals Company 1,3-benzodiazepin-2-ones and 1,3-benzoxazepin-2-ones useful as hiv reverse transcriptase inhibitors
GB9818731D0 (en) 1998-08-27 1998-10-21 Univ Portsmouth Compounds
AR021716A1 (en) 1998-12-18 2002-07-31 Schering Corp PROTEINA FARNESILO TRANSFER INHIBITORS.
CO5180550A1 (en) 1999-04-19 2002-07-30 Smithkline Beecham Corp FAB I INHIBITORS
AU7556800A (en) 1999-10-07 2001-05-10 Tadeka Chemical Industries, Ltd. Amine derivatives
EP1288216A1 (en) 2000-04-18 2003-03-05 Sumitomo Pharmaceuticals Company, Limited Tricyclic quinazolinediones
FR2812635B1 (en) * 2000-08-01 2002-10-11 Aventis Pharma Sa NOVEL HETEROCYCLIC COMPOUNDS, PREPARATION AND USE AS MEDICAMENTS IN PARTICULAR AS ANTI-BACTERIALS
EP1408970B1 (en) 2001-02-22 2007-05-09 School Of Pharmacy, University Of London Indolines and tetrahydro-quinolines as prodrugs for tumour treatment
FR2825705B1 (en) * 2001-06-08 2005-05-20 Aventis Pharma Sa NOVEL HETEROCYCLIC COMPOUNDS, THEIR PREPARATION AND THEIR USE AS MEDICAMENTS, IN PARTICULAR AS ANTI-BACTERIANS
FR2835186B1 (en) * 2002-01-28 2006-10-20 Aventis Pharma Sa NOVEL HETEROCYCLIC COMPOUNDS ACTIVE AS BETA-LACTAMASES INHIBITORS
US7439253B2 (en) * 2002-12-06 2008-10-21 Novexel Heterocyclic compounds, their preparation and their use as medicaments, in particular as antibacterials and beta-lactamase inhibitors

Also Published As

Publication number Publication date
CA2474043A1 (en) 2003-08-07
US20110245254A1 (en) 2011-10-06
CR7387A (en) 2010-10-25
SI1480644T1 (en) 2011-03-31
NO2016024I1 (en) 2016-12-15
CL2011000009A1 (en) 2011-03-25
NO20043587L (en) 2004-08-27
CN100563653C (en) 2009-12-02
IL163167A (en) 2010-04-15
NO335195B1 (en) 2014-10-20
ZA200405607B (en) 2005-09-28
EP2279737B1 (en) 2012-10-31
HK1077205A1 (en) 2006-02-10
US20050020572A1 (en) 2005-01-27
CN1994301A (en) 2007-07-11
KR100979079B1 (en) 2010-08-31
US20100048528A1 (en) 2010-02-25
FR2835186A1 (en) 2003-08-01
BRPI0307267B8 (en) 2021-05-25
WO2003063864A2 (en) 2003-08-07
CN1655781A (en) 2005-08-17
NL300847I2 (en) 2017-01-03
PE20030969A1 (en) 2003-12-12
TW200303305A (en) 2003-09-01
ES2356813T3 (en) 2011-04-13
HUS1600055I1 (en) 2017-01-30
WO2003063864A3 (en) 2004-03-11
BRPI0307267B1 (en) 2016-02-10
CN101406471A (en) 2009-04-15
SI2279737T1 (en) 2013-07-31
AR100790A2 (en) 2016-11-02
TWI293071B (en) 2008-02-01
AU2003214335B2 (en) 2007-04-05
EA007220B1 (en) 2006-08-25
JO2646B1 (en) 2012-06-17
RS52137B (en) 2012-08-31
TNSN04137A1 (en) 2007-03-12
NO2016024I2 (en) 2016-12-15
CN100482225C (en) 2009-04-29
CO5601014A2 (en) 2006-01-31
UA80271C2 (en) 2007-09-10
CY1111061T1 (en) 2015-06-11
DK2279737T3 (en) 2013-02-11
YU65804A (en) 2006-08-17
DE60334527D1 (en) 2010-11-25
JP2005523897A (en) 2005-08-11
MY140638A (en) 2010-01-15
CY2016042I2 (en) 2017-03-15
ES2401855T3 (en) 2013-04-25
BE2016C069I2 (en) 2022-05-17
ATE484281T1 (en) 2010-10-15
KR20040081473A (en) 2004-09-21
US7612087B2 (en) 2009-11-03
CR20120356A (en) 2012-10-05
EP1480644A2 (en) 2004-12-01
HRP20040686B1 (en) 2013-02-28
PL220725B1 (en) 2015-12-31
CY1114417T1 (en) 2016-08-31
OA12761A (en) 2006-07-04
UY27626A1 (en) 2003-08-29
JP4472346B2 (en) 2010-06-02
CA2474043C (en) 2011-08-02
NZ533936A (en) 2007-05-31
DK1480644T3 (en) 2011-01-24
PT1480644E (en) 2011-01-17
MXPA04006621A (en) 2004-10-04
PT2279737E (en) 2013-02-01
FR2835186B1 (en) 2006-10-20
HK1105864A1 (en) 2008-02-29
AR038234A1 (en) 2005-01-05
PL371601A1 (en) 2005-06-27
EA200400981A1 (en) 2005-02-24
EP1480644B1 (en) 2010-10-13
BR0307267A (en) 2004-12-07
MA26351A1 (en) 2004-10-01
ECSP045193A (en) 2004-08-27
LTC1480644I2 (en) 2018-09-10
LTPA2016037I1 (en) 2017-01-10
EP2279737A1 (en) 2011-02-02
US20090215747A1 (en) 2009-08-27
HRP20040686A2 (en) 2004-12-31

Similar Documents

Publication Publication Date Title
CY2016042I2 (en) NEW HETEROCYCLIC COMPOUNDS ACTIVE AS BETA-LACTAMAS INHIBITORS
IS7599A (en) Heterocyclic kinase inhibitors
IS8483A (en) Heterocyclic active agents for migraine
NO20043642L (en) Heterocyclic tripeptides such as hepatitis C inhibitors
NL1027811A1 (en) Heterocyclic amines as inhibitors of 11-hydroxy-steroid-dehydrogenase type 1.
DK2039685T3 (en) Heterobicyclic Compounds as P38 Inhibitors
DK1534290T3 (en) New kinase inhibitors
DE60320933D1 (en) RHO-KINASE INHIBITORS
ATE452891T1 (en) PYRIMIDOPYRIMIDONES AS KINASE INHIBITORS
NO20050665L (en) Pyrrolidone derivatives as MAOE inhibitors
DE50309032D1 (en) FUNGICIDAL ACTIVE COMPOUNDS
IS7505A (en) Pyrroleo-triazine aniline compounds are useful as kinase inhibitors
IS8348A (en) Synchronous heterocyclic compounds
IS7471A (en) New compounds
IS7879A (en) New compounds
DE602004008303D1 (en) TRIAZOLOPYRIMIDIN DERIVATIVES AS INHIBITORS OF GLYCOGENSYNTHASEKINASE-3
IS7827A (en) New compounds
IS7833A (en) Combined heterocyclic compounds
DE602004019555D1 (en) HETEROCYCLIC 7-AMINOALKYLIDENYLCHINOLONE AND -NAPHTHYRIDONE
ATE402700T1 (en) GLYCINAMIDE DERIVATIVES AS RAF-KINASE INHIBITORS
IS7585A (en) New piperadine compounds
IS7963A (en) Compounds with inhibitors of prolyloligopeptidase
DE60316425D1 (en) NF-kappaB INHIBITORS
SE0203606D0 (en) Heterocyclic compounds
SE0201185D0 (en) Heterocyclic compounds